Skip Navigation



JAC Advance Access published online on September 6, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf165
© 2002 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
50/4/445    most recent
dkf165v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Niumsup, P.
Right arrow Articles by Wuthiekanun, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Niumsup, P.
Right arrow Articles by Wuthiekanun, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 The British Society for Antimicrobial Chemotherapy

Original Paper

Cloning of the class D ß-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains

Pannika Niumsup 1* Vanaporn Wuthiekanun 2

1 Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanuloke 65000
2 Wellcome Trust Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand

* Corresponding author. E-mail: pannikan{at}nu.ac.th.

Received 10 January 2002 ; revised 11 June 2002 ; accepted 3 July 2002

Abstract

Ceftazidime is the antibiotic of choice for the treatment of melioidosis. Ceftazidime-resistant Burkholderia pseudomallei have been identified and ß-lactamase production implicated in resistance. In this study, 25 strains of B. pseudomallei (15 clinical and 10 environmental strains) were examined for their ability to yield mutants that overexpress ß-lactamase. Ceftazidime-resistant mutants were selected readily at high frequency and displayed four- to eight-fold increases in the MICs of ceftazidime. ß-Lactamase activities in both parent and mutant B. pseudomallei strains were examined by a spectrophotometric method. Twelve mutants (48%) showed approximately two- to 31-fold higher ceftazidimase activity compared with their parent strains and 10 (40%) demonstrated more than two-fold increases in imipenemase activity. A class D ß-lactamase gene from B. pseudomallei was cloned and sequenced. The encoded enzyme is an oxacillinase and is homologous to oxacillinases from Ralstonia pickettii and members of the genus Aeromonas. Reverse transcriptase PCR showed that transcription of the class D ß-lactamase gene is increased in ceftazidime-resistant mutants.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
I-C. Sam, K. H. See, and S. D. Puthucheary
Variations in Ceftazidime and Amoxicillin-Clavulanate Susceptibilities within a Clonal Infection of Burkholderia pseudomallei
J. Clin. Microbiol., May 1, 2009; 47(5): 1556 - 1558.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. C. Cheng and B. J. Currie
Melioidosis: Epidemiology, Pathophysiology, and Management
Clin. Microbiol. Rev., April 1, 2005; 18(2): 383 - 416.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. E. Keith, P. C. Oyston, B. Crossett, N. F. Fairweather, R. W. Titball, T. R. Walsh, and K. A. Brown
Functional Characterization of OXA-57, a Class D {beta}-Lactamase from Burkholderia pseudomallei
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1639 - 1641.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
C. Ong, C. H. Ooi, D. Wang, H. Chong, K. C. Ng, F. Rodrigues, M. A. Lee, and P. Tan
Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species
Genome Res., November 1, 2004; 14(11): 2295 - 2307.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Tribuddharat, R. A. Moore, P. Baker, and D. E. Woods
Burkholderia pseudomallei Class A {beta}-Lactamase Mutations That Confer Selective Resistance against Ceftazidime or Clavulanic Acid Inhibition
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2082 - 2087.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.